Enterprise record

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:bd231403-cb57-4a0b-a8d4-fc9dda4b42a1Version: public-1As of: unavailable

16 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 3 claims
    • Legal Name: Keros Therapeutics, Inc. · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026

  2. SEC DEF 14A 0001104659-26-046791

    sec def 14a · Source published: Apr 22, 2026 · Retrieved: Sep 6, 2026

    Supports 7 claims
    • Leadership Role: Jean-Jacques Bienaimé: Chair of the Board · Claim reviewed: Sep 28, 2026
    • Leadership Role: Charles Newton: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Jasbir Seehra: President, Chief Executive Officer and Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Esther Cho: Chief Legal Officer and Secretary · Claim reviewed: Sep 28, 2026
    • Leadership Role: Jasbir Seehra: President and Chief Executive Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Keith Regnante: Chief Financial Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Lorena Lerner: Chief Scientific Officer · Claim reviewed: Sep 28, 2026

  3. DEF 14A tm261345-1_def14a.htm

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Sep 2, 2026

    Supports 6 claims
    • Leadership Role: Alpna Seth: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Julius Knowles: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Mary Ann Gray: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Nima Farzan: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Ran Nussbaum: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Tomer Kariv: Director · Claim reviewed: Sep 28, 2026